178 related articles for article (PubMed ID: 14663643)
1. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
[TBL] [Abstract][Full Text] [Related]
2. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.
Collins RH; Piñeiro LA; Agura ED; Fay JW
Bone Marrow Transplant; 1998 Mar; 21(6):627-8. PubMed ID: 9580345
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
de Lavallade H; Faucher C; Fürst S; El-Cheikh J; Vey N; Coso D; Bouabdallah R; Stoppa AM; Gastaut JA; Blaise D; Mohty M
Bone Marrow Transplant; 2006 Apr; 37(7):709-10. PubMed ID: 16474410
[No Abstract] [Full Text] [Related]
4. [Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].
Okamura K; Ikeda T; Shimakura Y; Yoshiba F; Kishi K; Ando K; Hotta T
Rinsho Ketsueki; 2005 Jul; 46(7):527-31. PubMed ID: 16440747
[TBL] [Abstract][Full Text] [Related]
5. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
7. Prolymphocytic leukemia: diagnosis and treatment. A case report.
Akin C; Hansen P; Janckila A
J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
9. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
10. A brief intensive chemotherapy in T-prolymphocytic leukemia.
Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
[No Abstract] [Full Text] [Related]
11. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
IMAHASHI N; TOKUNAGA M; NISHIWAKI S; YANAGISAWA M; OZAWA Y; MIYAMURA K
Rinsho Ketsueki; 2009 Nov; 50(11):1612-5. PubMed ID: 20009435
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
[TBL] [Abstract][Full Text] [Related]
14. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ
Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506
[TBL] [Abstract][Full Text] [Related]
15. [Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
Valiev TT; Vinogradova IuE; Chernova NG; Mar'in DS; Volkova IaK; Petrova VI; Bulanov AIu; Kalinin NN; Semenova EA; Gretsov EM; Kravchenko SK; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2006; 78(7):87-90. PubMed ID: 16944758
[No Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis.
La Nasa G; Littera R; Cocco E; Battistini L; Marrosu MG; Contu L
Ann Hematol; 2004 Jun; 83(6):403-5. PubMed ID: 14648027
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease.
Castagna L; Nozza A; Bertuzzi A; Siracusano L; Timofeeva I; Santoro A
Bone Marrow Transplant; 2001 Dec; 28(12):1155-6. PubMed ID: 11803359
[TBL] [Abstract][Full Text] [Related]
18. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of B-cell prolymphocytic leukemia (B-PLL) with FCR-Lite (fludarabine, cyclophosphamide, rituximab) protocol].
Telek B; Batár P; Rejto L; Udvardy M
Orv Hetil; 2010 Aug; 151(31):1261-3. PubMed ID: 20656663
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia.
Bertz H; Potthoff K; Finke J
J Clin Oncol; 2003 Apr; 21(8):1480-4. PubMed ID: 12697870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
